Merger

Recorded: 2017-11-14 Pages: 23

Assignor

Executed: 2017-08-01

Assignee

ALFASIGMA S.P.A.

VIALE SARCA N. 223,, MILANO (MI),, ITALY

Covered Properties (8)

Carnitine and Inositol Phosphate-Containing Composition Useful as Dietary Supplement or Drug

Patent: 6,565,876 →

Application: 09/720,099 →

Gastro-Intestinal Adverse Effect-Free Composition Comprising an L-Carnitine Replacement

Patent: 6,441,039 →

Application: 09/740,787 →

Treating chronic uremic patients undergoing periodical dialysis

Patent: 6,335,369 →

Application: 09/761,639 →

Treating Chronic Uremic Patients Undergoing Periodical Dialysis

Patent: 6,429,230 →

Application: 09/971,076 →

Publication: US 2002/0052415

Salts of L-Carnitine and Lower Alkanoyl L-Carnitine

Patent: 6,703,042 →

Application: 09/979,880 →

Composition for the Prevention of Muscle Fatique and Skeletal Muscle Adaptation of Strenuous Exercise

Patent: 6,602,512 →

Application: 10/019,546 →

Treating Chronic Uremic Patients Undergoing Periodical Dialysis

Patent: 6,696,493 →

Application: 10/189,451 →

Publication: US 2002/0198263

Double Salts of Fumaric Acid with a Carnitine and an Amino Acid and Food Supplements, Dietary Supplements and Drugs Containing Same

Patent: 6,730,693 →

Application: 10/297,843 →

Publication: US 2003/0171417

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.